CanadaBis Capital Inc
XTSX:CANB
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.02
0.105
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
CanadaBis Capital Inc
XTSX:CANB
|
4.1m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
528.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.3B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.6B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
CanadaBis Capital Inc
Glance View
CanadaBis Capital Inc. is a capital pool company, which engages in the identification and evaluation of assets or a business. The company is headquartered in Rocky Mountain House, Alberta. The company went IPO on 2017-03-08. The Company’s segments include Wholesale, Retail, and Extraction and Tolling. The Wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards that are subsequently sold to end consumers. The Retail segment involves in the sale of cannabis and cannabis-related products to end consumers on premise owned and operated by the Company. The Extraction and Tolling segment provides cannabinoid extraction services to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd, Full Spectrum Labs Ltd, 2103157 Alberta Ltd. and Goldstream Cannabis Inc.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for CanadaBis Capital Inc is 1%, which is below its 3-year median of 10.4%.
Over the last 3 years, CanadaBis Capital Inc’s Operating Margin has decreased from 13.7% to 1%. During this period, it reached a low of 1% on Dec 1, 2025 and a high of 21.5% on Jul 31, 2023.